IPO of Vor Biopharma, Inc.

Vor Biopharma, Inc. has placed 9 287 017 shares in an IPO priced $18 per share which corresponds to the upper limit of the previously announced range ($16-18). Besides, Vor has granted the underwriters a 30-day option to purchase up to 1 474 202 shares at the public offering price. 

The trading debut will take place on the Nasdaq Global Select Market on February 5, 2021 under the ticker symbol “VOR”.